Tag: COPD
Pulmonologist Intervention Beneficial for Undiagnosed Asthma, COPD
Those receiving pulmonologist-directed treatment have less subsequent health care utilization for respiratory illness
Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 Inflammation
Increase seen in prebronchodilator forced expiratory volume in one second with dupilumab versus placebo at weeks 12, 52
Bisoprolol Does Not Reduce Exacerbations in At-Risk COPD Patients
No reduction seen in number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both
Female Reproductive Factors Linked to Risk for COPD
Age at menarche, number of children, number of miscarriages and stillbirths, age at natural menopause linked to COPD
American Lung Association Blasts Biden for Inaction on Menthol Cigarette Ban
Gabapentinoids Linked to Increased Risk for Severe Exacerbation in COPD
Compared with matched nonusers, gabapentinoid users have increased risk across indications of epilepsy, neuropathic pain, other chronic pain
Nitrate-Enriched Beetroot Juice Produces Reduction in Systolic BP in COPD
Active treatment lowered SBP, improved 6-minute walk test, improved measures of endothelial function
COPD Set to Reach About 600 Million Cases Worldwide by 2050
Number of cases projected to increase by 47.1 percent among women versus 9.4 percent among men by 2050
Prevalence of COPD Stable Overall From 2011 to 2021
Prevalence stable for most states and subgroups, but increased in those aged ≥75, micropolitan counties, current and former smokers
Physical Activity Inversely Tied to COPD Symptom Burden
Findings seen even in patients with mild or previously undiagnosed disease